Sorted By Test Name - Mayo Medical Laboratories

FMETF
91418
MTDNU
83129
3-8 years: 186-980 mcg/g creatinine
9-12 years: 110-582 mcg/g creatinine
13-17 years: 78-412 mcg/g creatinine
18-29 years: 131-467 mcg/g creatinine
30-39 years: 147-523 mcg/g creatinine
40-49 years: 164-585 mcg/g creatinine
50-59 years: 184-655 mcg/g creatinine
60-69 years: 206-733 mcg/g creatinine
> or =70 years: 230-821 mcg/g creatinine
Clinical References: 1. Ito Y, Obara T, Okamoto T, et al: Efficacy of single-voided urine
metanephrine and normetanephrine assay for diagnosing pheochromocytoma. World J Surg
1998;22:684-688 2. Hernandez FC, Sanchez M, Alvarez A, et al: A five-year report on experience in the
detection of pheochromocytoma. Clin Biochem 2000;33:649-655 3. Pacak K, Linehan WM, Eisenhofer
G, et al: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann
Intern Med 2001;134:315-329 4. Sawka AM, Singh RJ, Young WF Jr: False positive biochemical testing
for pheochromocytoma caused by surreptitious catecholamine addition to urine. Endocrinologist
2001;11:421-423
Metformin, Serum/Plasma
Reference Values:
Reporting limit determined each analysis
Synonym(s): Glucophage
Therapeutic range: Approximately 1-2 mcg/mL. Metformin
associated lactic acidosis generally has been associated
with Metformin plasma concentrations exceeding 5 mcg/mL.
Test Performed By: NMS Labs
3701 Welsh Road
P.O. Box 433A
Willow Grove, PA 19090-0437
Methadone Confirmation, Urine
Clinical Information: Methadone (Dolophine) is a synthetic opioid, a compound that is structurally
unrelated to the natural opiates but is capable of binding to opioid receptors. These receptor interactions
create many of the same effects seen with natural opiates, including analgesia and sedation. However,
methadone does not produce feelings of euphoria and has substantially fewer withdrawal symptoms than
opiates such as heroin.(1) Methadone is used clinically to relieve pain, to treat opioid abstinence
syndrome, and to treat heroin addiction in the attempt to wean patients from illicit drug use. Metabolism
of methadone to inactive forms is the main form of elimination. Oral delivery of methadone makes it
subject to first-pass metabolism by the liver and creates interindividual variability in its bioavailability,
which ranges from 80% to 95%. The most important enzymes in methadone metabolism are CYP3A4 and
CYP2B6.(1-4) CYP2D6 appears to have a minor role, and CYP1A2 may possibly be involved.(1-5)
Methadone is metabolized to a variety of metabolites, the primary metabolite is
2-ethylidene-1,5-dimethyl1-3,3-diphenylpyrrolidine (EDDP).(1-4) The efficiency of this process is prone
to wide inter- and intraindividual variability, due both to inherent differences in enzymatic activity as well
as enzyme induction or inhibition by numerous drugs. Excretion of methadone and its metabolites
(including EDDP) occurs primarily through the kidneys.(1,4) Patients who are taking methadone for
therapeutic purposes excrete both parent methadone and EDDP in their urine. Clinically, it is important to
measure levels of both methadone and EDDP. Methadone levels in urine vary widely depending on
factors such as dose, metabolism, and urine pH.(5) EDDP levels, in contrast, are relatively unaffected by
the influence of pH and are, therefore, preferable for assessing compliance with therapy.(5) Some patients
Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 1193